Jiachen Xu Selected Research

Jiachen Xu Research Topics

Disease

22	Neoplasms (Cancer) 03/2024 - 12/2019
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 01/2020
7	Lung Neoplasms (Lung Cancer) 10/2023 - 01/2021
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2022 - 06/2020
4	Disease Progression 01/2022 - 01/2018
3	Heart Failure 01/2024 - 07/2023
3	Inflammation (Inflammations) 07/2023 - 01/2023
3	Carcinoma (Carcinomatosis) 01/2021 - 12/2019
2	Hypertrophy 03/2024 - 01/2024
2	Fibrosis (Cirrhosis) 03/2024 - 01/2024
2	Myocardial Infarction 01/2024 - 01/2024
2	Wounds and Injuries (Trauma) 01/2024 - 01/2023
1	Adenocarcinoma of Lung 04/2024
1	Diabetic Cardiomyopathies 03/2024
1	Body Weight (Weight, Body) 03/2024
1	Cardiomegaly (Heart Hypertrophy) 01/2024
1	Infections 11/2023
1	Clostridium Infections 11/2023
1	Pneumonia (Pneumonitis) 11/2023
1	Starvation 11/2023
1	Melanoma (Melanoma, Malignant) 10/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2023
1	Tics (Tic) 05/2023
1	Lymphatic Metastasis 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 11/2022
1	Malignant Mesothelioma 06/2022
1	Adenocarcinoma 01/2022
1	Carcinogenesis 01/2022
1	Esophageal Squamous Cell Carcinoma 01/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022
1	Hamartoma 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Neutropenia 01/2021
1	Fatigue 01/2021
1	Deglutition Disorders (Dysphagia) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Exanthema (Rash) 10/2020
1	Tertiary Lymphoid Structures 10/2020

Drug/Important Bio-Agent (IBA)

9	Immune Checkpoint InhibitorsIBA 02/2024 - 06/2020
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2020
4	LigandsIBA 11/2022 - 12/2019
3	CalciumIBA 03/2024 - 01/2024
3	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2024 - 01/2023
2	Deubiquitinating EnzymesIBA 01/2024 - 01/2024
2	AntibodiesIBA 01/2023 - 10/2020
2	Monoclonal AntibodiesIBA 01/2022 - 10/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2022
1	AfatinibIBA 04/2024
1	Streptozocin (Streptozotocin)FDA Link 03/2024
1	Blood Glucose (Blood Sugar)IBA 03/2024
1	Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA 03/2024
1	CurcuminIBA 03/2024
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2024
1	Neoplasm Antigens (Tumor Antigens)IBA 02/2024
1	PolyubiquitinIBA 01/2024
1	Proteins (Proteins, Gene)FDA Link 01/2024
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2023
1	A 17 (A-17)IBA 11/2023
1	Azithromycin (Zithromax)FDA LinkGeneric 11/2023
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 11/2023
1	Doxycycline (Periostat)FDA LinkGeneric 11/2023
1	CalcineurinIBA 11/2023
1	Angiotensin IIIBA 07/2023
1	ginsenoside Rg5IBA 07/2023
1	Indicators and Reagents (Reagents)IBA 05/2023
1	osimertinibIBA 01/2023
1	AntigensIBA 01/2023
1	CollagenIBA 01/2023
1	CytokinesIBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	ChemokinesIBA 11/2022
1	Histone Deacetylase InhibitorsIBA 11/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	PlasticsIBA 01/2022
1	Leucovorin (Folinic Acid)FDA Link 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	TabletsIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	icotinibIBA 01/2022
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2021
1	Lipase (Acid Lipase)FDA Link 01/2021
1	Transforming Growth Factor-beta Type II ReceptorIBA 01/2021
1	tyrosine receptor (receptor, tyrosine)IBA 12/2020
1	EphrinsIBA 12/2020
1	Phosphotransferases (Kinase)IBA 12/2020
1	toripalimabIBA 10/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2020
1	Amylases FDA Link 10/2020
1	B7-H1 AntigenIBA 01/2020

Therapy/Procedure

19	Immunotherapy 03/2024 - 12/2019
10	Therapeutics 10/2023 - 01/2020
5	Drug Therapy (Chemotherapy) 05/2023 - 10/2020
1	Adjuvant Chemotherapy 01/2021